091440 — Hanwool Materials Science Balance Sheet
0.000.00%
- KR₩82bn
- KR₩129bn
- KR₩17bn
Annual balance sheet for Hanwool Materials Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 22,644 | 8,854 | 521 | 9,706 | 19,793 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9,562 | 12,102 | 3,588 | 7,713 | 5,328 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 49,852 | 34,713 | 18,141 | 29,139 | 43,346 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,158 | 5,490 | 17,419 | 11,919 | 52,752 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 62,449 | 47,467 | 44,764 | 42,929 | 129,216 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 31,904 | 26,163 | 20,343 | 14,806 | 25,645 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 41,852 | 33,206 | 28,213 | 20,904 | 87,430 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 20,598 | 14,261 | 16,551 | 22,025 | 41,786 |
Total Liabilities & Shareholders' Equity | 62,449 | 47,467 | 44,764 | 42,929 | 129,216 |
Total Common Shares Outstanding |